Correlation Between Acceleron Pharma and US Bancorp

Can any of the company-specific risk be diversified away by investing in both Acceleron Pharma and US Bancorp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acceleron Pharma and US Bancorp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acceleron Pharma and US Bancorp, you can compare the effects of market volatilities on Acceleron Pharma and US Bancorp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acceleron Pharma with a short position of US Bancorp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acceleron Pharma and US Bancorp.

Diversification Opportunities for Acceleron Pharma and US Bancorp

0.0

Correlation Coefficient

Acceleron Pharma  US Bancorp

Pay attention - limited upside

The 3 months correlation between Acceleron and USB is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Acceleron Pharma and US Bancorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US Bancorp and Acceleron Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acceleron Pharma are associated (or correlated) with US Bancorp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US Bancorp has no effect on the direction of Acceleron Pharma i.e., Acceleron Pharma and US Bancorp go up and down completely randomly.

Pair Corralation between Acceleron Pharma and US Bancorp

If you would invest  4,375  in US Bancorp on February 3, 2024 and sell it today you would lose (278.00) from holding US Bancorp or give up 6.35% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Acceleron Pharma  vs.  US Bancorp

Acceleron Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acceleron Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Acceleron Pharma is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

US Bancorp

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in US Bancorp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, US Bancorp is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Acceleron Pharma and US Bancorp

The main advantage of trading using opposite Acceleron Pharma and US Bancorp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acceleron Pharma position performs unexpectedly, US Bancorp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in US Bancorp will offset losses from the drop in US Bancorp's long position.

The idea behind Acceleron Pharma and US Bancorp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.